AIP Advances,
Journal Year:
2024,
Volume and Issue:
14(5)
Published: May 1, 2024
Concentration
plays
an
essential
role
in
generating
hydroxyl
radicals
irradiated
nanoenhancer
suspensions.
In
this
paper,
we
used
coumarin-3-carboxylic
acid
as
a
radical-specific
probe
to
investigate
the
radical
production
of
different
concentration
nanodiamonds
(NDs)
and
CeO2
NPs
phosphate-buffered
saline
under
x-ray
irradiation.
NDs
significantly
enhanced
production,
maximum
enhancement
was
observed
at
10
µg/ml,
with
factor
1.398
±
0.262.
can
increase
scavenge
ranges,
lowest
highest
factors
0.623
0.069
1.738
0.264,
respectively.
We
tested
hydrodynamic
diameter
various
concentrations
explore
effect
further.
found
that
increasing
concentration,
there
might
be
factors,
such
recombination
nanoparticle
agglomeration,
lead
changes
factor.
Based
on
data
from
previous
present
studies,
experimental
results
indicate
is
for
generation
suspensions
ionizing
radiation.
also
provide
possible
mechanisms
enhancing
by
nanoenhancers
water
radiation
decrease
high
nanoenhancers.
Acta Pharmaceutica Sinica B,
Journal Year:
2023,
Volume and Issue:
13(11), P. 4391 - 4416
Published: May 20, 2023
Owing
to
the
inherent
shortcomings
of
traditional
therapeutic
drugs
in
terms
inadequate
efficacy
and
toxicity
clinical
treatment,
nanomedicine
designs
have
received
widespread
attention
with
significantly
improved
reduced
non-target
side
effects.
Nanomedicines
hold
tremendous
theranostic
potential
for
treating,
monitoring,
diagnosing,
controlling
various
diseases
are
attracting
an
unfathomable
amount
input
research
resources.
Against
backdrop
exponentially
growing
number
publications,
it
is
imperative
help
audience
get
a
panorama
image
activities
field
nanomedicines.
Herein,
this
review
elaborates
on
development
trends
nanomedicines,
emerging
nanocarriers,
vivo
fate
safety
their
extensive
applications.
Moreover,
challenges
obstacles
hindering
translation
nanomedicines
also
discussed.
The
elaboration
aspects
may
enlighten
readers
set
route
future
endeavors.
MedComm – Oncology,
Journal Year:
2024,
Volume and Issue:
3(1)
Published: March 1, 2024
Abstract
Rapid
growth
in
nanoparticles
(NPs)
as
delivery
systems
holds
vast
promise
to
promote
therapeutic
approaches
for
cancer
treatment.
Presently,
a
diverse
array
of
NPs
with
unique
properties
have
been
developed
overcome
different
challenges
and
achieve
sophisticated
routes
enhancement
series
therapies.
Inspiring
advances
achieved
the
field
therapy
using
NPs.
In
this
review,
we
aim
summarize
up‐to‐date
progression
addressing
various
challenges,
expect
elicit
novel
potential
opportunities
alternatively.
We
first
introduce
sorts
NP
technologies,
illustrate
their
mechanisms,
present
applications.
Then,
achievements
made
by
break
obstacles
delivering
cargoes
specific
sites
through
particular
are
highlighted,
including
long‐circulation,
tumor
targeting,
responsive
release,
subcellular
localization.
subsequently
retrospect
recent
research
treatments
from
single
therapy,
like
chemotherapy,
combination
chemoradiotherapy,
integrative
therapy.
Finally,
perspectives
impact
on
oncology
discussed.
believe
review
can
offer
deeper
understanding
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(13), P. 15718 - 15729
Published: March 20, 2024
Surgical
removal
of
tumor
tissue
remains
the
primary
clinical
approach
for
addressing
breast
cancer;
however,
complete
excision
is
challenging,
and
remaining
cells
can
lead
to
recurrence
metastasis
over
time,
which
substantially
deteriorates
life
quality
patients.
With
aim
improve
local
cancer
radiotherapy,
this
work
reports
fabrication
alginate
(Alg)
scaffolds
containing
bovine
serum
albumin
(BSA)-coated
bismuth
sulfide
(Bi2S3@BSA)
nanoradiosensitizers
using
three-dimensional
(3D)
printing.
Under
single-dose
X-ray
irradiation
in
vitro,
Alg-Bi2S3@BSA
significantly
increase
formation
reactive
oxygen
species,
enhance
inhibition
cells,
suppress
their
colony
capacity.
In
addition,
implanted
under
murine
model
show
high
therapeutic
efficacy
by
reducing
volume
growth
rate
irradiation,
while
histological
observation
main
organs
reveals
no
cytotoxicity
or
side
effects.
3D-printed
produced
with
biocompatible
biodegradable
materials
may
potentially
lower
rates
patients
inhibiting
residual
following
postsurgery
as
well
exhibit
anticancer
properties
other
solid
tumors.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(29)
Published: June 3, 2024
Abstract
Exploring
efficient
and
low‐toxicity
radiosensitizers
to
break
through
the
bottleneck
of
radiation
tolerance,
immunosuppression
poor
prognosis
remains
one
critical
developmental
challenges
in
radiotherapy.
Nanoheterojunctions,
due
their
unique
physicochemical
properties,
have
demonstrated
excellent
radiosensitization
effects
energy
deposition
lifting
tumor
radiotherapy
inhibition.
Herein,
they
doped
selenium
(Se)
into
prussian
blue
(PB)
construct
a
nano‐heterojunction
(Se@PB),
which
could
promote
increase
Fe
2+
/Fe
3+
ratio
conversion
Se
high
valence
state
with
introduction.
The
‐Se‐Fe
electron
transfer
chain
accelerates
rate
on
surface
nanoparticles,
turn
endows
it
X‐ray
transport
capability,
enhances
physical
sensitivity.
Furthermore,
Se@PB
induces
glutathione
(GSH)
depletion
accumulation
pro‐Fenton
reaction,
thereby
disturbs
redox
balance
cells
biochemical
sensitivity
As
an
radiosensitizer,
effectively
induced
mitochondrial
dysfunction
DNA
damage,
promotes
cell
apoptosis
synergistic
cervical
cancer
This
study
elucidates
mechanism
Se‐doped
nanoheterojunction
from
perspective
biochemistry
provides
low‐toxic
strategy
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 5, 2024
Radiotherapy
(RT),
essential
for
treating
various
cancers,
faces
challenges
from
tumor
hypoxia,
which
induces
radioresistance.
A
tumor-targeted
"prosthetic-Arginine"
coassembled
nanozyme
system,
engineered
to
catalytically
generate
nitric
oxide
(NO)
and
oxygen
(O
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 20, 2025
Nanotechnology
has
become
a
groundbreaking
innovation
force
in
cancer
therapy,
offering
innovative
solutions
to
the
limitations
of
conventional
treatments
such
as
chemotherapy
and
radiation.
By
manipulating
materials
at
nanoscale,
researchers
have
developed
nanocarriers
capable
targeted
drug
delivery,
improving
therapeutic
efficacy
while
reducing
systemic
toxicity.
Nanoparticles
like
liposomes,
dendrimers,
polymeric
nanomaterials
shown
significant
promise
delivering
chemotherapeutic
agents
directly
tumor
sites,
enhancing
bioavailability
minimizing
damage
healthy
tissues.
In
addition
with
utilization
tools
quantum
dots
nanosensors
that
enables
more
precise
identification
biomarkers,
nanotechnology
is
also
playing
pivotal
role
early
detection
diagnosis.
Furthermore,
nanotechnology-based
strategies,
including
photothermal
gene
therapy
immunotherapy
are
novel
ways
combat
by
selectively
targeting
cells
immune
response.
Nevertheless,
despite
these
progressions,
obstacles
still
persist,
particularly
clinical
translation
technologies.
Issues
nanoparticle
toxicity,
biocompatibility,
complexity
regulatory
approval
hinder
widespread
adoption
nanomedicine
oncology.
This
review
discusses
different
applications
highlighting
its
potential
hurdles
implementation.
Future
research
needs
concentrate
on
addressing
unlock
full
providing
personalized,
effective,
minimally
invasive
treatments.
Sustainability,
Journal Year:
2025,
Volume and Issue:
17(5), P. 2100 - 2100
Published: Feb. 28, 2025
The
extraction
of
metallic
nanoparticles
(MNPs)
from
waste
electrical
and
electronic
equipment
(WEEE)
has
gained
extensive
attention
researchers
for
eco-friendly,
reliable,
sustainable
alternative
protocol
over
the
traditional
linear
economic
approach
(make-use-dispose)
boosting
circular
economy.
A
plethora
MNPs
including
metals/metal
oxide
having
a
size
dimension
ranging
1–100
nanometers
(nm)
have
been
extracted
these
WEEE
by
using
different
chemical,
physical,
biological
methods.
Recovery
certain
precious
can
be
achieved
dismantling
recycling
items
in
form
gold
(Au),
platinum
(Pt),
zinc
(ZnO),
silver
(Ag),
copper
(CuO).
These
provide
huge
range
applications
such
as
antibacterial,
therapeutic,
target
drug
delivery,
biotechnological
applications.
This
comprehensive
review
provides
in-depth
knowledge
synthesis
techniques
delves
into
their
potential
biomedical
fields
with
mechanisms.
article
also
discussed
global
challenges
opportunities
this
area
adopting
concept
economy
to
conserve
natural
resources
future
generations
hence
create
greener
environment
protect
our
planet.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(11), P. 2438 - 2438
Published: May 22, 2024
Radiotherapy
is
an
essential
component
of
the
treatment
regimens
for
many
cancer
patients.
Despite
recent
technological
advancements
to
improve
dose
delivery
techniques,
escalation
required
enhance
tumor
control
limited
due
inevitable
toxicity
surrounding
healthy
tissue.
Therefore,
local
enhancement
dosing
in
sites
can
provide
necessary
means
modality.
In
years,
emergence
nanotechnology
has
facilitated
a
unique
opportunity
increase
efficacy
radiotherapy
treatment.
The
application
high-atomic-number
(Z)
nanoparticles
(NPs)
augment
effects
by
increasing
sensitivity
cells
radiation.
High-Z
NPs
inherently
act
as
radiosensitizers
well
serve
targeted
vehicles
radiosensitizing
agents.
this
work,
therapeutic
benefits
high-Z
radiosensitizers,
such
their
tumor-targeting
capabilities
and
mechanisms
sensitization,
are
discussed.
Preclinical
data
supporting
status
clinical
translation
will
be
presented.
International Journal of Particle Therapy,
Journal Year:
2024,
Volume and Issue:
13, P. 100626 - 100626
Published: Aug. 8, 2024
Particle
Therapy
(PT)
represents
a
significant
advancement
in
cancer
treatment,
precisely
targeting
tumor
cells
while
sparing
surrounding
healthy
tissues
thanks
to
the
unique
depth-dose
profiles
of
charged
particles.
Furthermore,
their
linear
energy
transfer
and
relative
biological
effectiveness
enhance
capability
treat
radioresistant
tumors,
including
hypoxic
ones.
Over
years,
extensive
research
has
paved
way
for
PT's
clinical
application,
current
efforts
aim
refine
its
efficacy
precision,
minimizing
toxicities.
In
this
regard,
radiobiology
is
evolving
towards
integrating
biotechnology
advance
drug
discovery
radiotherapy
(RT)
optimization.
This
shift
from
basic
understanding
molecular
mechanisms
PT
aims
expand
therapeutic
window
through
innovative
dose
delivery
regimens
combined
therapy
approaches.
review,
written
by
over
30
contributors
various
countries,
provides
comprehensive
look
at
key
areas
new
developments
radiobiology,
emphasizing
innovations
techniques
transforming
field,
ranging
irradiation
modalities
multimodal
radiation
therapy,
modeling
efforts.
We
highlight
both
advancements
knowledge
gaps,
with
improving
application
oncology.